PTGS2 and cancer: As the levels of PGE2 and COX-2 are often elevated in cancers such as CRC [283, 284], COX-2 inhibitors especially COXIBs (selective COX-2 inhibitors) were developed, with potent anti-inflammatory activities without affecting the physiological functions of COX-1 [285].